This Ethics course gives the student an understanding and appreciation of ethical issues that currently affect the pharmaceutical and health industries. The purpose of medical research is to benefit society by the systematic acquisition of useful, empirical knowledge driven by a desire to understand the causes of disease or dysfunction and find effective methods of prevention or treatment.
In extreme cases, however, even such humanitarian aims can be risky. Especially as the very potential for achieving tangible benefits can feed the temptation to press on beyond acceptable boundaries, and arguments about an anticipated greater good are commonly invoked by those willing to sacrifice the rights of research subjects.
In addition to humanitarian aims, scientific curiosity is another major impetus for experimentation. After all, the achievements of modern medicine were developed through experimentation, which for the most part was probably responsibly conducted according to the standards and theories available at the time. Some research, however, involves such risk or definite harm for the participants that it clearly falls outside all acceptable parameters. Coerced participation in research is clearly abusive but lack of opportunity to participate can also be so. These are some of the issues addressed in the course.
On successful completion of this course, students will be able to:
-Evaluate the ethical suitability of research methodologies for the purpose of undertaking research in regulatory sciences especially with respect to vulnerable groups
-Critically review the ethical issues involved in the undertaking of clinical research
-Recognise the subjectivity in ethical issues that impact on the research of human and non-human subjects and construct reasoned arguments for their own or others’ opinions
-Demonstrate the ability to formulate effective and ethical leadership tools in Regulatory Sciences
• Introduction to Ethics
• Reproductive Ethics
• What Makes Research Ethical
• End-of-Life Decision Making
• Research and Vulnerable Groups
• Vulnerable Groups and the Developing World
• Animal Research
• Obligations of the Pharmaceutical Industry
Contact | Information material
For further information about our in-house seminars, company terms and conditions or questions regarding our content please get in touch with us via email, phone or the contact form. We would also be pleased to send you our 'Offers for companies' information brochure. We look forward to hearing from you.
Director Distance Learning
Tel.: +49 (0) 6221 487 8061
Please contact me directly or use the quick & easy
Contact form for corporate customers
Date | Price | Audience
Duration | Workload | Certificate:
4 weeks | 30 hours of tutor guided learning activities | Certificate of completion by Healthcare Learning
€ 1.000,- (plus VAT)
Companies can book this course for their employees directly at Springer Campus. If you are an employee of a company and would like to take this course, please contact your HR department so that they can book the course for you at Springer Campus.